Medicinal chemistry

View all stories within this topic.

  • Tomorrow's vaccines - designed and made in the lab

    Synthetic vaccines

    1 May 2010

    The design of synthetic vaccines offers a more systematic approach to vaccine therapy for many illnesses, including cancer, and even drug addiction

  • A sailor using a telescope
    The Mole

    Lost at sea: could you find your way using alchemy?

    1 January 2010

    On screen chemistry with Jonathan Hare

  • Joseph Lister

    Solving an infectious problem

    1 September 2009

    Joseph Lister's use of phenol as an antiseptic revolutionised surgical practice in the 19th century. But was he the first to use this antiseptic technique?

  • image - Feaure - Hargreaves - main

    Catalysts for a green industry

    1 July 2009

    Chemists are working to develop new, longer-lasting catalysts to ensure industrial processes are cleaner, greener and more efficient

  • Kew's greenhouse
    The Mole

    Kew the celebrations

    1 May 2009

    The Royal Botanic Gardens, Kew, celebrates 250 years of horticulture and science.

  • Electrical discharges from the nerve cells in the brain

    Epilepsy - beyond bromide

    1 May 2009

    An historical journey into the treatment of epilepsy, starting with potassium bromide 150 years ago

  • Feet on weighing scales
    The Mole

    Obesity – at what cost

    1 March 2009

    Do drugs have a part to play in controlling obesity?

  • mosquito
    The Mole

    Antimalarial drugs

    1 January 2009

    Approximately one million people die annually from malaria worldwide. Tragically, 90 per cent of these deaths are among the under-fives in sub-Saharan Africa, who have little if any access to adequate healthcare. Drugs are used to treat the disease but parasitic resistance to these drugs is growing, so what is ...

  • image - feature - dhume-klair - main 1

    Microbial iron scavengers

    1 January 2009

    Medicinal and analytical chemists take their cue from micro-organisms' ability to bind to iron in the design of new drugs and sensors

  • The dendrimer-based active ingredient (blue and red) in Starpharma's anti-HIV agent VivaGel binds to specific receptors (yellow) on the surface of HIV, preventing fusion with human cells

    Nanomedicine arrives

    1 July 2008

    Nanoscale chemical entities target the building blocks of biology with medicinal consequences